Adam Dorr: AI will make medical breakthroughs monthly and bypass FDA gatekeeping
adam_dorr · x · 2026-09-25
Responding to Derek Thompson's caution that AI bio discoveries will take years to prove as "the next CRISPR," Adam Dorr argues that's incumbent thinking. He predicts AI will deliver medical marvels monthly with globally available tech, and gray-market labs will let most people skip years-long trials — citing retatrutide as precedent — making FDA gatekeeping ethnocentric and shortsighted.
More from AGI Musings
- Should leading AI labs face radical transparency at the cost of trade secrets? — dhadfieldmenell · 2026-09-25
- The New Yorker: There is no AI "race" — first to invent rarely wins — jjding99 · 2026-09-25
- Same AI tools are making every app look identical, just like algorithmic content — vhanagwal · 2026-09-25
- AI Benchmarks Now Test Real Lab Science Skills, Not Just QA — 141_1337 · 2026-09-25
- Study: top AI experts badly underestimated how fast the field is moving — The Decoder · 2026-09-25
- Researcher Warns AI Is Breeding Nihilism Among Scientists; Jack Clark Responds — doomslide · 2026-09-25